Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ Continued Access Protocol: Post-Approval Continued Follow-up

NCT02892955 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT02892955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02892955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ Continued Access Protocol: Post-Approval Continued Follow-up
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2016
Completion date
March 31, 2021
Enrollment
1,685 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

advanced refractory left ventricular heart failure